These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 14739490

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New insights into the genetics of familial chromaffin cell tumors.
    Koch CA, Vortmeyer AO, Zhuang Z, Brouwers FM, Pacak K.
    Ann N Y Acad Sci; 2002 Sep; 970():11-28. PubMed ID: 12381538
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Familial pheochromocytomas and paragangliomas: stories from the sign-out room.
    Perren A, Komminoth P.
    Endocr Pathol; 2006 Sep; 17(4):337-44. PubMed ID: 17525482
    [Abstract] [Full Text] [Related]

  • 5. Familial pheochromocytoma.
    Erlic Z, Neumann HP.
    Hormones (Athens); 2009 Sep; 8(1):29-38. PubMed ID: 19269919
    [Abstract] [Full Text] [Related]

  • 6. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU, Gutsche M, Gläsker S, Müller B, Kirste G, Eng C, Neumann HP.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [Abstract] [Full Text] [Related]

  • 7. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
    Fishbein L.
    Curr Cardiol Rep; 2019 Jul 31; 21(9):104. PubMed ID: 31367972
    [Abstract] [Full Text] [Related]

  • 8. Genetic testing for pheochromocytoma-associated syndromes.
    Pawlu C, Bausch B, Reisch N, Neumann HP.
    Ann Endocrinol (Paris); 2005 Jun 31; 66(3):178-85. PubMed ID: 15988378
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H.
    JAMA; 1995 Oct 11; 274(14):1149-51. PubMed ID: 7563486
    [Abstract] [Full Text] [Related]

  • 11. Pheochromocytoma: the expanding genetic differential diagnosis.
    Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL.
    J Natl Cancer Inst; 2003 Aug 20; 95(16):1196-204. PubMed ID: 12928344
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW, Brouwers FM, Lubensky IA, Vortmeyer AO, Weil RJ, Walther MM, Oldfield EH, Linehan WM, Pacak K, Zhuang Z.
    J Clin Endocrinol Metab; 2005 Jun 20; 90(6):3747-51. PubMed ID: 15769989
    [Abstract] [Full Text] [Related]

  • 13. [Genetics of pheochromocytoma and the relevance in surgery].
    von Dobschütz E, Neumann HPH.
    Chirurg; 2019 Jan 20; 90(1):15-22. PubMed ID: 30306232
    [Abstract] [Full Text] [Related]

  • 14. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G, Stanojević B, Palmar I, Dimitrijević B.
    Srp Arh Celok Lek; 2002 Jul 20; 130 Suppl 2():52-7. PubMed ID: 12584999
    [Abstract] [Full Text] [Related]

  • 15. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
    Benn DE, Dwight T, Richardson AL, Delbridge L, Bambach CP, Stowasser M, Gordon RD, Marsh DJ, Robinson BG.
    Cancer Res; 2000 Dec 15; 60(24):7048-51. PubMed ID: 11156410
    [Abstract] [Full Text] [Related]

  • 16. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1995 Dec 15; 79():L-LV. PubMed ID: 8600671
    [Abstract] [Full Text] [Related]

  • 17. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G, Conton P, Schiavi F, Macino B, Mantero F.
    Fam Cancer; 2005 Dec 15; 4(1):13-6. PubMed ID: 15883705
    [Abstract] [Full Text] [Related]

  • 18. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER, Eng C, McMahon R, Voutilainen R, Affara NA, Ponder BA, Maher ER.
    Hum Mol Genet; 1997 Jul 15; 6(7):1051-6. PubMed ID: 9215674
    [Abstract] [Full Text] [Related]

  • 19. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
    Guo Z, Lloyd RV.
    Adv Anat Pathol; 2015 Sep 15; 22(5):283-93. PubMed ID: 26262510
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
    Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PL, O'Riordan JL, Toledo SP.
    J Med Genet; 1995 Dec 15; 32(12):934-7. PubMed ID: 8825918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.